Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 3/20 | 0.39 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | PAM | P19021 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.35 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | POLA1 | P09884 | 1/20 | 0.35 |
| ▸ | NAAA | Q02083 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27577356 | 0.93 | TSHR (0.42) | DGKALMNAMAPTKMT2APAM | |
| SCHEMBL28921483 | 0.85 | MAPT (0.57) | DGKALMNAMAPTKMT2APAM | |
| SCHEMBL27403983 | 0.85 | MAPT (0.57) | DGKALMNAMAPTKMT2APAM | |
| SCHEMBL2037784 | 0.84 | TDP1 (0.43) | LMNATDP1CYP1A2TSHRALDH1A1 | |
| SCHEMBL9593713 | 0.83 | DGKA (0.42) | DGKALMNAMAPTKMT2APAM | |
| SCHEMBL2180897 | 0.83 | DGKA (0.42) | DGKALMNAMAPTKMT2APAM | |
| SCHEMBL1065353 | 0.83 | DGKA (0.42) | DGKALMNAMAPTKMT2APAM | |
| SCHEMBL515782 | 0.83 | DGKA (0.42) | DGKALMNAMAPTKMT2APAM | |
| SCHEMBL9593894 | 0.83 | DGKA (0.42) | DGKALMNAMAPTKMT2APAM | |
| SCHEMBL1064431 | 0.83 | DGKA (0.42) | DGKALMNAMAPTKMT2APAM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4673157-A2 | COMPOSITIONS FOR MODULATING GUT MICROFLORA POPULATIONS, TREATMENT OF DYSBIOSIS AND DISEASE PREVENTION, AND METHODS FOR MAKING AND USING SAME | Persephone Biosciences, Inc. (US) | 2026-01-07 | — | — | EP | disclosed |
| WO-2024182434-A2 | COMPOSITIONS FOR MODULATING GUT MICROFLORA POPULATIONS, TREATMENT OF DYSBIOSIS AND DISEASE PREVENTION, AND METHODS FOR MAKING AND USING SAME | PERSEPHONE BIOSCIENCES, INC. (US) | 2024-09-06 | — | — | WO | disclosed |
| US-10920283-B2 | Methods to establish and restore normal gut microbiota function of subject in need thereof | WASHINGTON UNIVERSITY | 2021-02-16 | — | — | US | disclosed |
| US-20170281740-A1 | SERODIAGNOSIS OF SALMON POISONING DISEASE | OHIO STATE INNOVATION FOUNDATION | 2017-10-05 | — | — | US | disclosed |
| EP-3132021-A2 | AMMONIA-OXIDIZING NITROSOMONAS EUTROPHA STRAIN D23 | Aobiome LLC (US) | 2017-02-22 | — | — | EP | disclosed |
| US-20170037363-A1 | AMMONIA-OXIDIZING NITROSOMONAS EUTROPHA STRAIN D23 | AOBIOME LLC (US) | 2017-02-09 | — | — | US | disclosed |
| US-20160326574-A1 | METHODS TO ESTABLISH AND RESTORE NORMAL GUT MICROBIOTA FUNCTION OF SUBJECT IN NEED THEREOF | WASHINGTON UNIVERSITY | 2016-11-10 | — | — | US | disclosed |
| WO-2015160911-A2 | AMMONIA-OXIDIZING NITROSOMONAS EUTROPHA STRAIN D23 | AOBIOME LLC (US) | 2015-10-22 | — | — | WO | disclosed |
| WO-2015066625-A1 | METHODS TO ESTABLISH AND RESTORE NORMAL GUT MICROBIOTA FUNCTION OF SUBJECT IN NEED THEREOF | WASHINGTON UNIVERSITY (US) | 2015-05-07 | — | — | WO | disclosed |
| US-20100028952-A1 | FERMENTATION AND PURIFICATION OF ACTINOMADURA CHROMOPROTEIN AND RELATED SPECIES | WYETH (US) | 2010-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100028952-A1 | FERMENTATION AND PURIFICATION OF ACTINOMADURA CHROMOPROTEIN AND RELATED SPECIES | DCXR, ACTR2, AMY2A | DGKA 2930/4885LMNA 4265/4885MAPT 1079/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.